Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00069082 · ClinicalTrials.gov registry record · Phase 3
Intranasal Civamide for Episodic Cluster Headache
A Phase 3 study, sponsored by Winston Laboratories.
- Completed
- Registry status
- Phase 3
- Development phase
- 2
- Enrollment target
NCT00069082: Completed Phase 3 study, sponsored by Winston Laboratories.
NCT00069082 is a Phase 3 study that has completed, run by Winston Laboratories. The registered enrollment target is 2 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00069082, a Phase 3 study, has completed, sponsored by Winston Laboratories.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2 participants
- Enrollment target
Study Summary
This is a 49-day study to evaluate the effectiveness of Intranasal Civamide (Zucapsaicin) in the treatment of an episodic cluster headache period compared to placebo (medically inactive substance which does not contain any active ingredients).
Interventions
- DRUG Sodium Chloride
- DRUG Civamide (Zucapsaicin)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2003-08 |
| Est. Completion | 2004-01 |
| Phase | Phase 3 |
What the finished NCT00069082 record still lists
NCT00069082 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Sodium Chloride is the first listed.
NCT00069082 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00069082 about?
NCT00069082 is a clinical study titled "Intranasal Civamide for Episodic Cluster Headache". This is a 49-day study to evaluate the effectiveness of Intranasal Civamide (Zucapsaicin) in the treatment of an episodic cluster headache period compared to placebo (medically inactive substance which does not contain any active ingredients).
What is the current status of trial NCT00069082?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2 participants. The study started on 2003-08. Estimated completion is 2004-01.
What interventions are being tested in trial NCT00069082?
The interventions under investigation include: Sodium Chloride (DRUG), Civamide (Zucapsaicin) (DRUG).
Who is sponsoring clinical trial NCT00069082?
This trial is sponsored by Winston Laboratories, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00069082's enrollment target sits among peer trials
2 2000th of 2000 the lowest of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia